GLOBAL 3D BIOPRINTED CAPSULES MARKET

INTRODUCTION

The ability of a 3D printed capsule co-formulated with the permeation enhancer sodium caprate to transport the synthetic octapeptide octreotide in beagle dogs was assessed.

The capsule is made to break free from the physiological pressures in the antropyloric area. Traditional enteric coated hard gelatin capsules and enteric coated tablets were contrasted with the pressure sensitive capsules. 

Using a bottom-up assembly method, 3D biological structures are created by depositing biomaterials or biomaterials combined with cells in predefined patterns layer by layer.

Replicating the structure, makeup, and complexity of human tissues is now possible thanks to technology, which could ultimately result in the development of whole organ engineering for medical applications.

GLOBAL 3D BIOPRINTED CAPSULES MARKET SIZE AND FORECAST

The Global 3D bioprinted capsules market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.

RECENT PARTNERSHIP

The multinational pharmaceutical giant Merck has made plans to collaborate with AMCM, an EOS Group company that creates specialised additive manufacturing equipment.

The two businesses will collaborate on designing and manufacturing 3D printed tablets, initially for use in clinical trials and subsequently for mass production.

"Our relationship with AMCM / EOS has the potential to change the way tablets are made," said Merck's Chief Strategy Officer. The sector will undergo a significant shift toward digitization.

The purpose of powder bed fusion, in which powder is melted and fused together layer by layer by a laser, is to create pharmaceuticals. AM is anticipated to speed up and reduce the cost of tablet manufacturing by enabling the avoidance of reformulations during pharmaceutical development and commercial production. Additionally, 3D printing offers the flexibility to adjust to patient needs.

COMPANY PROFILE

• Aprecia Pharmaceuticals
• FabRx
• Merck
• Triastek, Inc.
• GlaxoSmithKline

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. What is the average cost perGlobal 3D bioprinted capsules marketright now and how will it change in the next 5-6 years?
2. Average cost to set up aGlobal 3D bioprinted capsules marketin the US, Europe and China?
3. How manyGlobal 3D bioprinted capsules marketare manufactured per annum globally? Who are the sub-component suppliers in different regions?
4. What is happening in the overall public, globally?
5. Cost breakup of aGlobal 3D bioprinted capsules marketand key vendor selection criteria
6. Where is theGlobal 3D bioprinted capsules market manufactured? What is the average margin per equipment?
7. Market share ofGlobal 3D bioprinted capsules marketmanufacturers and their upcoming products
8. The most important plannedGlobal 3D bioprinted capsules marketin next 2 years
9. Details on network of majorGlobal 3D bioprinted capsules marketand pricing plans
10. Cost advantage for OEMs who manufactureGlobal 3D bioprinted capsules marketin-house
11. 5 key predictions for next 5 years inGlobal 3D bioprinted capsules market
12. Average B-2-BGlobal 3D bioprinted capsules marketprice in all segments
13. Latest trends inGlobal 3D bioprinted capsules market, by every market segment
14. The market size (both volume and value) ofGlobal 3D bioprinted capsules marketin 2022-2030 and every year in between?
15. Global production breakup ofGlobal 3D bioprinted capsules market, by suppliers and their OEM relationship